Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia
Launched by SHANGHAI MENTAL HEALTH CENTER · Jan 11, 2019
Trial Information
Current as of September 03, 2025
Unknown status
Keywords
ClinConnect Summary
Our research hypothesis：1. Medically assisted Acupuncture in schizophrenia can improve negative symptoms；2. Drug assisted Acupuncture Therapy has better cognitive function in schizophrenic patients than single drug；3. Schizophrene with acupuncture have fewer and lighter adverse reactions。This study was carried out only in Shanghai Mental Health Center. It was a parallel randomized study.Schizophrene with negative symptoms were treated with atypical antipsychotic drug amisulpride, but still remained negative symptoms. Using the mature Chinese medicine therapy acupuncture auxiliary treatment,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The diagnosis of schizophrenia according to International classification diagnosis-10(ICD-10)
- • patients at an age between 18～60 years old of Han nationality
- Exclusion Criteria:
- • other psychiatric diagnoses
- • Suffering from serious physical disease and can not accept the treatment
- • Patients to be diagnosed according to ICD-10 for substance abused, development delayed
- • Inability to sign informed consent because of capacity due due to severe mental illness, significant psychomotor agitation or slowness test completion
- • claustrophobic
- • metal implantation in vivo
About Shanghai Mental Health Center
Shanghai Mental Health Center is a leading institution dedicated to advancing mental health research and treatment. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and evidence-based practices to address a wide range of psychiatric disorders. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to enhancing patient care through rigorous clinical trials that contribute to the understanding and management of mental health conditions. Its mission is to foster collaboration among researchers, clinicians, and patients to promote mental well-being and improve outcomes in mental health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Zhenghui YI
Principal Investigator
SHANGHAI MENTAL HEALTH CENTRE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials